Compare Orchid Pharma with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DISHMAN PHARMA - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DISHMAN PHARMA ORCHID PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x -79.7 25.1 - View Chart
P/BV x 22.8 3.3 682.5% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ORCHID PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
DISHMAN PHARMA
Mar-16
ORCHID PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs194374 51.8%   
Low Rs35129 27.2%   
Sales per share (Unadj.) Rs276.5197.8 139.8%  
Earnings per share (Unadj.) Rs-79.221.2 -373.5%  
Cash flow per share (Unadj.) Rs-43.534.7 -125.1%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs53.9179.9 30.0%  
Shares outstanding (eoy) m70.4580.69 87.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.3 32.6%   
Avg P/E ratio x-1.411.9 -12.2%  
P/CF ratio (eoy) x-2.67.2 -36.4%  
Price / Book Value ratio x2.11.4 151.8%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m8,06720,306 39.7%   
No. of employees `0002.80.8 337.8%   
Total wages/salary Rs m2,5275,355 47.2%   
Avg. sales/employee Rs Th6,956.119,252.7 36.1%   
Avg. wages/employee Rs Th902.56,459.5 14.0%   
Avg. net profit/employee Rs Th-1,993.02,064.1 -96.6%   
INCOME DATA
Net Sales Rs m19,47715,961 122.0%  
Other income Rs m407265 153.4%   
Total revenues Rs m19,88416,226 122.5%   
Gross profit Rs m1,1034,103 26.9%  
Depreciation Rs m2,5191,091 231.0%   
Interest Rs m5,227944 553.5%   
Profit before tax Rs m-6,2362,334 -267.2%   
Minority Interest Rs m200-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125624 -20.1%   
Profit after tax Rs m-5,5801,711 -326.1%  
Gross profit margin %5.725.7 22.0%  
Effective tax rate %2.026.7 7.5%   
Net profit margin %-28.710.7 -267.2%  
BALANCE SHEET DATA
Current assets Rs m11,01411,018 100.0%   
Current liabilities Rs m32,0609,517 336.9%   
Net working cap to sales %-108.19.4 -1,149.1%  
Current ratio x0.31.2 29.7%  
Inventory Days Days95110 85.9%  
Debtors Days Days3435 96.3%  
Net fixed assets Rs m29,44016,304 180.6%   
Share capital Rs m705161 436.5%   
"Free" reserves Rs m2,04312,907 15.8%   
Net worth Rs m3,80014,516 26.2%   
Long term debt Rs m9,0184,189 215.3%   
Total assets Rs m46,51029,805 156.0%  
Interest coverage x-0.23.5 -5.6%   
Debt to equity ratio x2.40.3 822.3%  
Sales to assets ratio x0.40.5 78.2%   
Return on assets %-0.88.9 -8.5%  
Return on equity %-146.911.8 -1,245.8%  
Return on capital %-3.717.5 -21.3%  
Exports to sales %37.924.8 152.8%   
Imports to sales %22.63.7 605.5%   
Exports (fob) Rs m7,3783,956 186.5%   
Imports (cif) Rs m4,406596 738.9%   
Fx inflow Rs m7,5134,952 151.7%   
Fx outflow Rs m5,649697 810.7%   
Net fx Rs m1,8654,255 43.8%   
CASH FLOW
From Operations Rs m1,6822,786 60.4%  
From Investments Rs m-9,860-1,529 644.9%  
From Financial Activity Rs m6,644-941 -706.0%  
Net Cashflow Rs m-1,535316 -485.1%  

Share Holding

Indian Promoters % 32.3 61.4 52.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 3.7 124.3%  
FIIs % 3.3 12.7 26.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 22.1 250.2%  
Shareholders   84,811 46,261 183.3%  
Pledged promoter(s) holding % 54.9 35.8 153.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   WOCKHARDT  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  FULFORD INDIA  

Compare ORCHID PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Mar 2, 2021 03:36 PM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 8-QTR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS